FdaApplication
NDA 209935
Identifiers
- fda_app_no: NDA209935
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2017-05-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | 2.5MG;EQ 200MG BASE | TABLET;ORAL |
1 product